Missense point mutations can inactivate p53 and this is the most common genetic event linked with human cancer p53 is able to recognize and bind sites of DNA damage Prives, 1994; Hollstein et al., 1996) . It and, in some way, damage to cellular DNA activates a is also possible that abnormal regulation of p53 may p53 response leading to G 1 arrest or apoptosis. We contribute to the development of those tumours expressing have previously shown that 'damaged DNA' induces wild-type protein (see Milner, 1995a). However, the N-terminal cleavage of p53 to generate p40(ΔN) and molecular mechanisms operating to regulate p53 are poorly p35 (core) protein products. We now show that the understood. It is likely that post-translational modification p35 product has protease activity and is able to cleave plays a regulatory role and, indeed, p53 is subject to between residues 23 and 24 of full-length p53 to numerous phosphorylations/dephosphorylations, but the generate a novel product, p50(ΔN23). This activity was functional significance of such modifications is, as yet, inhibited by bestatin, an aminopeptidase inhibitor.
Introduction
during mitogenic stimulation of primary T lymphocytes (Milner, 1984) . These various changes may involve postThe p53 tumour suppressor is able to induce growth arrest translational modification(s), interaction with co-factors, or apoptosis in DNA-damaged cells and in this way p53 conformational shifts and/or protein-protein interactions. protects against genetic instability and predisposition to
Overall they indicate possible allosteric regulation of p53 cancer (for recent reviews see Gottlieb and Oren, 1996 ; (Cook and Milner, 1990; Milner et al., 1991; Hupp and Kastan, 1996; Levine, 1997) . InducLane, 1994; reviewed in Milner, 1995b ). tion of G 1 arrest is dependent upon sequence-specific A crucial step in regulation of p53 concerns its activation DNA binding and transcriptional activation of p53 target in response to DNA damage. This process appears to be genes such as p21 WAF-1/CIP-1 (hereafter termed p21; Elindependent of gene transcription and may operate at the Diery et al., 1993; Harper et al., 1993; Xiong et al., 1993;  levels of translation and/or post-translation of p53 protein for a review see Gottlieb and Oren, 1996) . p21 is an (Nelson and Kastan, 1994; Fu et al., 1996) . Activation is inhibitor of cyclin dependent kinase (CDK) and blocks the marked by increased levels of cellular p53 and/or increased activity of G 1 cyclin-CDK complexes. In cells induction of sequence-specific DNA binding and transactivation of p53 p21 can block phosphorylation and inactivation of the target genes (Tishler et al., 1993; Nelson and Kastan, retinoblastoma protein, thus contributing to G 1 arrest 1994; Siegel et al., 1995) . DNA double-strand breaks can (Slebos et al., 1994) . Other genes up-regulated by p53 activate p53 and the system appears to be exquisitely may also contribute to cell growth arrest.
sensitive since as little as a single double-strand break Induction of apoptosis is less well understood. Recent work indicates that induction of apoptosis by p53 can be may be sufficient to activate a cellular p53 response (Di Leonardo et al., 1994; Nelson and Kastan, 1994; reviewed in Kastan, 1996) . The p53 protein can bind at sites of DNA damage such as dsDNA ends, ssDNA and insertion/deletion (IDL) mismatches (Oberosler et al., 1993; Jayaraman and Prives, 1995; Lee et al., 1995; Reed et al., 1995) . The structural domain of p53 involved in binding to sites of DNA damage is the C-terminal 14 kDa domain. Other stimuli may also serve to activate p53, since it responds to: (i) ribonucleotide depletion in the absence of detectable DNA damage (Linke et al., 1996) ; (ii) inhibition of RNA polymerase activity (Ljungman and Zhang, 1996) . It is also theoretically possible that different agents may activate p53 by different mechanisms. containing full-length p53 was 1 in 7. Samples were analysed by 15% SDS-PAGE and immunoblotted using PAb240 as probe with detection and p35 (core) products (Molinari et al., 1996) . The p35
by chemiluminescence (see Materials and methods). (B) Identical to core was conformationally intact and was released from (A) except that the DNA used in the initial incubation reaction was the p53-DNA complexes under all conditions tested. We now p53 target sequence CON. Full-length p53 and its cleavage products
show that the p35 product has protease activity and is are indicated by arrows. M, marker p53.
able to cleave the N-terminus of full-length p53 to generate a novel product, p50(ΔN23). Unexpectedly, interaction with ssDNA was found to induce C-terminal cleavage of A dsDNA oligonucleotide containing a triple cytosine insertion was used to induce cleavage of p53 purified p53 and generate p50(ΔC) and p40(ΔC). The functional significance of these various p53 cleavage products in from Sf9 insect cells (as detailed in Molinari et al., 1996) . Interaction with this L-dsDNA induces: (i) N-terminal relation to the cellular response to DNA damage is discussed.
cleavage to yield a p40 product which remains bound to the residual full-length p53-DNA complexes; (ii) N-plus C-terminal cleavage to give a conformationally intact core
Results
domain of p53 which is released into the supernatant. Freshly purified p53 was incubated with L-dsDNA at The observation that interaction with damaged DNA induces proteolytic cleavage of p53 in vitro (Molinari 37°C for 60 min, after which time p53-DNA complexes were pelleted and the supernatant harvested. An aliquot et al., 1996) led us to consider that the protein may have intrinsic protease activity. p53 assembles into homologous of the supernatant was taken for analysis by immunoblotting and, as expected, contained a single band correstetramers and may therefore be susceptible to either intramolecular processing (within a p53 monomeric subponding to the p35 cleavage product of p53 ( Figure 1A , s/natant fraction). An equivalent aliquot of the supernatant unit) and/or intermolecular processing (between neighbouring p53 molecules). In order to investigate the (containing p35) was added to fresh full-length p53, mixed and incubated at 37°C. Samples were withdrawn from possibility of intermolecular processing we have now asked if p53 has the capacity to cleave other p53 molecules.
the incubation mix at various times and analysed by immunoblotting, using PAb240 as probe. At the time of mixing the presence of full-length p53 and the p35 p35 cleaves the N-terminus of full-length p53 Purified full-length p53 protein is stable in solution unless cleavage product were evident in the incubation mix ( Figure 1A , time zero). Prolonged exposure of the immunoincubated in the presence of DNA. Interaction with either L-dsDNA or with ssDNA induces selective and limited blot failed to reveal any other protein bands (not shown). Subsequently, two additional bands with apparent molecucleavage of p53 protein (Molinari et al., 1996 ; see also Figure 1B ). We therefore reasoned that interaction with lar weights of 50 (p50) and 40 kDa (p40) were clearly detectable between 5 and 60 min incubation ( Figure 1A ). DNA might somehow activate p53 as a protease and that such activation might involve removal of a negative During this period the amount of p35 core fragment remained essentially unchanged, indicating that p35 is regulatory domain(s) from the protein. Obvious candidates for screening were the cleavage products generated by only generated in the presence of damaged DNA. It should be noted that there was a dilution factor of 1 in 7 on interaction with DNA. In this study the p35 core fragment has been tested since it is relatively easy to harvest addition of p35 to the solution containing full-length p53 (Materials and methods). This accounts for the lower following its release from p53-DNA complexes.
Biotinylated DNA bound to streptavidin-coated beads intensity of signal observed for p35 in lanes 0-60 min relative to the supernatant fraction ( Figure 1A , s/natant was employed in these experiments, since this permits separation of p53-DNA complexes from any products lane).
The above experiment included two negative controls. released into the supernatant (Materials and methods). Table I ). Aliquots of those samples the p35 core fragment (see Figures 1 and 2 ). This region also contains shown in Figure 1 were subject to analyses by further immunoblotting, an α-helical motif with residues important for interfacing with mdm2, using PAb242 (against an N-terminal epitope) and PAb421 (C-terminal a negative regulator of p53 function (Kussie et al., 1996 ; see epitope) as probes. Solid arrows, reactive p53 and its cleavage Discussion). products; hollow arrows, positions of non-reactive protein bands.
In the first the primary incubation was with CON dsDNA, Table I . Effects of protease inhibitors on N-terminal cleavage of p53 which contains a specific p53 target sequence and is bound to generate p53(ΔN23) by the p53 core domain (Funk et al., 1992) . Sequence-
Inhibitor
Specificity Cleavage specific binding to CON DNA does not induce proteolytic cleavage of p53 (Molinari et al., 1996) and, as expected, was stable up to 12 h prolonged incubation (not shown).
aprotinin, 2 μg/ml; leupeptin, 0.5 μg/ml; E64, 10 μg/ml; bestatin, 40 μg/ml; phosphoramidon, 300 μg/ml.
The second control was designed to check against the unlikely possibility that L-dsDNA bound to streptavidincoated beads might release some component into the the PAb242 epitope ( Figure 2 , lower panel). As expected, full-length p53 was reactive with both N-and C-terminal supernatant which is capable of inducing proteolytic cleavage of full-length p53. In these experiments biotinylmonoclonal antibodies, whereas the p35 central core fragment was negative for PAb242 and PAb421 (Figure ated L-dsDNA was bound to streptavidin-coated beads and incubated in the absence of p53. An aliquot of the 2; positions of positive bands indicated by solid arrows, positions of non-reactive protein bands indicated by hollow supernatant from this incubation was added to full-length p53, mixed and analysed at various times as described for arrows). These results indicate that both p50 and p40 are generated by N-terminal cleavage of p53, hereafter termed Figure 1 . Again, no proteolytic cleavage of the full-length protein was detectable and the results (not shown) were p50(ΔN) and p40(ΔN) respectively. essentially the same as those presented in Figure 1B .
Overall, these results indicate that the p35 core fragment
Determination of the N-terminal cleavage site of p50(ΔN) by microsequencing of p53 has protease activity and is able to cleave fulllength p53 and generate p50 and p40 cleavage products. p50(ΔN) represents a novel cleavage fragment of p53 and the cleavage site was next determined by microsequencing. Prolonged incubation did not result in further cleavage of the residual full-length p53 observed in Figure 1A ,
The results revealed that the site of cleavage was between Trp23 and Lys24; the product is hereafter termed suggesting that the process is self limiting under the conditions of the experiment. p50(ΔN23). This site and its flanking residues are conserved between murine and human p53 (see Figure 3 ). p50 and p40 are generated by N-terminal cleavage of p53 Generation of p50(ΔN23) is blocked by bestatin, an aminopeptidase inhibitor The results presented in Figure 1 were obtained using the monoclonal antibody PAb240 for immunoblotting. This
The generation of p50(ΔN23) proved to be resistant to a range of protease inhibitors (Table I) , including aprotinin antibody detects a highly conserved epitope within the central core domain of p53 (residues 212-217). In order and leupeptin (inhibitors of serine proteases), E64 and leupeptin (cysteine proteases), pepstatin (aspartate proto characterize p50 and p40 in more detail we performed additional immunoblots, using PAb242 to detect the teases) and phosphoramidon (metalloendopeptidases). However, bestatin, an aminopeptidase inhibitor, effectively N-terminus of murine p53 (residues 18-27). The C-terminus was detected using PAb421 (residues 370-blocked generation of p50(ΔN23) ( Table I Fig. 4 . Cleavage of p53 when incubated in the presence of ssDNA and p40(ΔC) 0 ϩ ϩ 0 comparison of the effects of ssDNA with free 3Ј-and 5Ј-ends. p53 (core) 0 0 ϩ 0 Identical DNA oligonucleotides were biotinylated at either the 5Ј-end p50(ΔC) a ϩ b ϩ 0 (3Ј-free) or the 3Ј-end (5Ј-free) and incubated with freshly prepared p53 for 60 min (Materials and methods). After incubation supernatant a Cleavage product induced by treatment of ML-1 cells with samples were analysed by immunoblotting using PAb240 as probe.
adriamycin or cisplatin. M, full-length p53 marker; 5Ј, ssDNA with 5Ј-end free; 3Ј, ssDNA b DO-1 monoclonal antibody against the N-terminus of human p53. with 3Ј-end free.
analogue which blocks the reaction (Taylor, 1993) . In this context it should be noted that the p35 cleavage product of p53 represents a conformationally intact core domain and is predicted to contain a single zinc atom Molinari et al., 1996) . Since p35 also appears to exhibit protease activity and can cleave the N-terminus of p53 (Figures 1 and 2 ) we suggest that p35 may be associated with aminopeptidase activity.
C-terminal cleavage of p53 induced by interaction with 3Ј-free ssDNA
In previous studies we have observed that ssDNA also the 3Ј-and 5Ј-ends of ssDNA may differ in their molecular interaction with p53, since the protein has intrinsic 3Ј→5Ј exonuclease activity (Mummenbrauer et al., 1996) . The cleavage of the protein. Two novel p50(ΔC) and p40(ΔC) cleavage products were generated and released from the experimental protocol used in our present study employs DNA which has been biotinylated at one end and bound protein-DNA complexes. Overall, these results indicate that p53 interacts differentially with the 3Ј-and 5Ј-ends to streptavidin-coated beads. This effectively blocks one end of the ssDNA molecule and we reasoned that this of ssDNA. may influence the interaction between p53 and the end of the ssDNA, depending on which end of the ssDNA is Kinetics of p53 cleavage induced by ssDNA in vitro Time course studies were next carried out in order to available for protein interaction. We therefore compared the effects of 3Ј-and 5Ј-biotinylation on proteolytic determine the sequence of appearance of p53 cleavage fragments following binding to 3Ј-free ssDNA. The supercleavage of p53. The DNA molecules will be identified by their free ends, 3Ј-free (5Ј-biotinylated) and 5Ј-free natants from p53-ssDNA complexes were harvested at given times and analysed for p53 by immunoblotting with (3Ј-biotinylated), and the same 53mer oligonucleotide was used throughout (see Materials and methods).
PAb240. Previous studies have indicated that ATP can influence the release of p53 and its cleavage products Incubation of p53 with 5Ј-free ssDNA induced release of the p35 cleavage product (Figure 4) . No additional from DNA (Molinari et al., 1996) and we therefore performed parallel incubations in the presence and absence cleavage products were detectable and this result is the same as has been reported previously (Molinari et al., of ATP. Initial p53-DNA complexes were obtained (Materials and methods) and equivalent aliquots of sample 1996). In contrast, a novel cleavage pattern was obtained for p53 incubated with 3Ј-free ssDNA. With these incubwere divided equally and incubated in the presence or absence of ATP (5 mM). Under both conditions of ations p50 and p40 products were released from the p53-DNA complexes, in addition to the p35 core domain incubation p50(ΔC) was clearly detectable at 5 min and did not appear to decrease or increase upon prolonged (Figure 4) . Further characterization by immunoblotting with PAb242 and PAb421 revealed that p50 and p40 were incubation up to 60 min ( Figure 5 ). These results suggest that p50 is a stable product of p53 and is generated within generated by C-terminal cleavage of p53 (Table II) , hereafter termed p50(ΔC) and p40(ΔC).
less than 5 min of p53 binding to ssDNA. Longer incubations were necessary before p40(ΔC) and Thus, when the 3Ј-end of ssDNA is available for interaction with p53 we unexpectedly observed C-terminal p35 cleavage products were detectable. In the presence of ATP the p40(ΔC) product was barely detectable at 5 min, cleavage of p53 and induction of p21 expression occuring between 3 and 6 h exposure to the drug ( Figure 6B ). but subsequently accumulated to relatively high levels during the 60 min incubation period (Figure 5, upper Under the conditions of the experiments both adriamycin and cisplatin induced G 1 arrest and apoptosis of ML-1 panel). In the absence of ATP the generation of p40 appeared to be delayed ( Figure 5 , lower panel), being first cells ( Figure 6C ; F.Ponchel and J.Milner, unpublished observations). detectable at 30 min. The p35 core product of p53 was also detectable at 30 min and here the kinetics were independent of the presence of ATP (Figure 5 , compare upper and lower panels; note that these results represent Discussion equal exposure times for the immunoblots and are strictly p53 is a modular protein and its functional domains have comparable). Interestingly, the appearance of p40(ΔC) and been explored by genetic mutation and deletion analyses. p35 correlated with a decrease in full-length p53 (Figure The N-terminus, for example, interacts with cellular tran-5, compare samples taken at 30 and 60 min). scriptional elements and is necessary for transactivation Another point of note in these results is the release of of p53 target genes. The central core domain (residues full-length p53 from p53-ssDNA complexes ( Figure 5) .
102-292 ) is also necessary for transcriptional activation A high level of p53 in the supernatant was evident within and precise conformational folding of this domain is 1 min incubation in the presence of ATP, whereas in the required to orientate those residues which physically absence of ATP no full-length p53 was detectable until interact with specific DNA target sequences (Cho et al., the 5 min incubation period (Figure 5, compare upper and 1994) . The C-terminus of p53 contains the oligomerization lower panels). Others have shown that p53 binds ATP domain (residues 324-355) which forms dimers and tetra-(Brain and Jenkins, 1994) and it is well established that mers, formed from a dimer of dimers (Clore et al., 1994) . many DNA binding proteins utilize ATP to promote
The C-terminus is also involved in recognition and binding conformational changes which allow assembly with, or at sites of DNA damage and this property is likely to dissociation from a DNA target (Thiagaligam and prove crucial for activation of the p53 response (Lee et al., Grossman, 1993; Cox, 1994; Hegde et al., 1996) . No 1995). Once activated, p53 is able to orchestrate numerous hydrolysis of ATP was detectable in our experiments and cellular control pathways and induce growth arrest in G 1 ATP did not block p53-ssDNA binding (A.Okorokov and of the cell cycle. Alternatively, p53 initiates apoptosis. A J.Milner, unpublished observations). Our present results number of factors influence the choice between growth thus suggest that ATP may in some way modify the arrest and apoptosis and recent work indicates that these affinity of p53-ssDNA complexes, possibly due to some are genetically separable pathways ; conformational shift of the protein. It is likely that the reviewed in Gottlieb and Oren, 1996 ; increased levels of p53 released into the supernatant may Polyak et al., 1996; Rowan et al., 1996; Levine, 1997) . account for the elevated levels of cleavage products But how is p53 activated in the first place? On the basis obtained in the presence of ATP compared with the of our results we now propose that selective functions of absence of ATP ( Figure 5 , upper panel versus lower panel). p53 may be activated by proteolytic cleavage of the protein and that this process is triggered by interaction of C-terminal cleavage of p53 occurs in vivo and p53 with sites of DNA damage. Moreover, cleavage can correlates with up-regulation of target gene occur either at the N-terminus or at the C-terminus and expression can be determined by the nature of the DNA which Deletion of 30 residues from the extreme C-terminus of induces the primary cleavage reaction (i.e. L-dsDNA or p53 activates its functions as a transcription factor (see ssDNA; Molinari et al., 1996 ; this paper). We have Discussion) and C-terminal cleavage may thus provide previously discussed the possibility that damaged DNA one mechanism for activating p53 in vivo following may act as a co-factor to trigger autoproteolysis of p53 exposure of cells to DNA damage. In order to test this (Molinari et al., 1996) and our present results are consistent possibility we treated human ML-1 cells with either with the notion that interaction with damaged DNA may adriamycin or cisplatin (Materials and methods) and initiate a cascade of proteolytic cleavage steps linked with analysed cellular p53 protein by immunoblotting with activation of p53 protein. different monoclonal antibodies. Following drug treatment a second lower p53 band was detected with PAb240 ( Figure 6A upper panel, arrows indicate the p53 doublet)
N-terminal cleavage and p53 function
We have now shown that the p35 (core) fragment of p53 and also with DO-1, which detects an N-terminal epitope on human p53 (results not shown). The mobility of the has protease activity and cleaves the extreme N-terminus of full-length p53 (Figures 1 and 2 ). Microsequencing lower band corresponded approximately with p50(ΔC) and its reactivity with both PAb240 and DO-1 is strong revealed that the cleavage site was between Trp23 and Lys24 (Figure 3) . Although the N-terminus is required for evidence that it is a p53-derived product. Only full-length p53 was detectable with PAb421 ( Figure 6A ), indicating transactivation of p53 target genes there is evidence that the extreme N-terminus is dispensible for this property. that the lower protein band lacked the C-terminal 421 epitope of p53. For cells treated with adriamycin the This was clearly demonstrated by who reported that an engineered deletion mutant of p53 C-terminal cleavage of p53 was first detectable 3 h after treatment and correlated with up-regulation of p21, a lacking the first 22 amino acids (ΔN22) is both transcriptionally active and as potent at inducing apoptosis as wildknown target of activated p53 ( Figure 6A ). Similar results were obtained for cells treated with cisplatin, except type p53. It is likely that p50(ΔN23) may be equally functional and experiments are underway to determine its that the kinetics were slightly delayed, with C-terminal Fig. 6 . C-terminal cleavage of endogenous wild-type p53 and up-regulation of p21 expression in ML-1 cells. Cells were treated with either adriamycin (1 μg/ml) or cisplatin (10 μg/ml) and analysed for p53 and p21 expression by 15% SDS-PAGE and immunoblotting (Materials and methods; p21 monoclonal antibody was from Santa Cruz, clone sc-817). The double arrows indicate full-length p53 (upper arrow) and the faster migrating p53-derived product (lower arrow) detected by PAb240; the same doublet was observed with DO-1 (not shown), which detects an N-terminal epitope on human p53. Only full-length p53 was detected by PAb421. p53 and p21 proteins are as indicated. Positions of molecular weight and p53 markers are not included in the figure transactivation potential and ability to induce apoptosis in therefore predicted to seriously impair the ability of mdm2 to bind p50(ΔN23). It follows that transactivation of target transfected cells.
However, p50(ΔN23) is almost certain to differ from gene expression by p50(ΔN23) is likely to be resistant to down-regulation by mdm2. This is represented schematicthe intact protein in at least one important respect. This concerns the protein-protein binding between p53 and ally in Figure 7 . A second N-terminal cleavage site generates p40(ΔN) mdm2, a negative regulator of p53 transactivation and apoptotic activity (Lin et al., 1994; Chen,J. et al., 1995, and involves loss of the transactivation domain (within residues 1-42; Unger et al., 1993) and removal of the 1996; Haupt et al., 1996) . The crystal structure of the p53-mdm2 interface shows that interaction relies on steric epitope recognized by PAb248 (residues 44-60; see Molinari et al., 1996 ; Table I ). This cleavage is predicted complementarity between mdm2 and p53. In particular, this involves residues Phe19, Trp23 and Leu26, which are to enhance transcriptional repression and also the DNA and RNA reannealing properties of p53 (Brain and Jenkins, located on the hydrophobic face of the p53 α-helix (Kussie et al., 1996) . Removal of both Phe19 and Trp23 is 1994; Horikoshi et al., 1995) . It should be noted that p53
induces C-terminal cleavage of p53 to generate p50(ΔC). Based upon the change in molecular weight we calculate a loss of~30 residues from the C-terminus. A similarly sized product of endogenous wild-type p53 was observed in vivo following exposure of cells to adriamycin or cisplatin ( Figure 6 ). This p53-derived product lacked the C-terminus and its appearance correlated with cellular upregulation of p21. We therefore suggest that p50(ΔC) is a natural cleavage product of p53 and may be activated for transactivation of p53 target genes in vivo. The p50(ΔC) cleavage product has an intact N-terminus and should therefore retain sensitivity to mdm2 feedback inhibition (see Figure 7 ).
Different types of DNA 'damage' induce different p53 cleavage products
Interaction with L-dsDNA induces N-terminal cleavage of p53 (Molinari et al., 1996) and it was therefore a suprise when we discovered that ssDNA induces C-terminal cleavage under identical conditions (Results). This led us to review in detail the literature relating to we have developed a provisional model for the putative fragment (Molinari et al., 1996; this paper) . In its turn p35 promotes role(s) of proteolytic cleavage in the p53 response to DNA N-terminal cleavage of full-length p53 to generate p50(ΔN23) (arrow damage (summarized in Figure 7 ). 1) . This N-terminal truncated product may have the same capacity to transactivate p53 target genes and induce apoptosis as ΔN22 (arrows 2
We propose that the ability of p53 to exhibit a differential and 3; see Discussion) . However, p50 ( apoptosis. For example, repair of damaged DNA involves 1992; . One target gene is mdm2, which mechanisms such as nucleotide excision repair and stranded intermediates would contribute towards the maintenance of G 1 arrest during the repair process. Thus the period of cell growth arrest would be tailored to fit can be a substrate for proteolytic cleavage by calpains (Kubbutat and Vousden, 1997; Pariat et al., 1997) with the time required for DNA repair. Moreover, since the C-terminus of p53 appears important for an efficient an N-terminal cleavage site. However, calpain cleavage of p53 is inhibited by chelating agents (Pariat et al., 1997) apoptotic response , its removal will minimize the apoptotic potential of p50(ΔC) and favour and is therefore unrelated to the cleavage induced by damaged DNA, since the latter is resistant to the presence cell growth arrest. If, on the other hand, a cell sustains heavy damage to of chelating agents (Molinari et al., 1996) .
its DNA, the balance may be tipped towards apoptosis by N-terminal cleavage of p53 to produce p50(ΔN23). As
C-terminal cleavage
The last 30 residues of p53 constitute a negative regulatory discussed above, p50(ΔN23) is likely to be competent for transactivation of p53 target genes and for induction of domain with potent suppression of sequence-specific DNA binding by p53 and transactivation of target genes. Deletion apoptosis. However, it has lost a major part of the mdm2 binding interface (hydrophobic residues Phe19 and Trp23) of the C-terminus activates specific DNA binding in vitro and transactivation of target gene expression in transfected and may therefore be resistant to feedback regulation by mdm2. Under these conditions p50(ΔN23) may promote cells (Hupp et al., 1992; Halazonetis and Kandil, 1993; Cox et al., 1995; Pellegata et al., 1995; apoptosis (see Figure 7) . The apoptotic pathways may be preceded by a transient growth arrest, reflecting up-1996) . Using an inducible expression system showed that p53(ΔC30) up-regulates expression of regulation of target genes such as p21. Indeed, this is exactly what is observed when ΔN22 is expressed in cells p21 as efficiently as the wild-type protein. Interestingly, however, ΔC30 was much less effective than wild-type . A key player in this scenario is p35, the core fragment of p53 which is released from in induction of apoptosis. Similar results were recently obtained for alternatively spliced murine p53 (p53AS) p53-DNA complexes. In this paper we show that p35 has protease activity and is able to cleave the N-terminus of (Almog et al., 1997) . These observations indicate that the C-terminal amino acids of p53 are necessary for efficient p53 to generate p50(ΔN23). In this way p35 may serve to reinforce the p53 response to cellular DNA damage. apoptotic activity.
In this paper we report that interaction with ssDNA In summary, intact p53 protein appears to encompass a activation of p53 following DNA damage and also for regulating the choice between cell growth arrest and
Cell culture and cell cycle analysis apoptosis.
ML-1 cells (derived from a human myeloblastic leukaemia and expressing wild-type p53) were cultured at 37°C in 5% CO 2 in air in RPMI 1640 supplemented with 10% fetal calf serum, 100 μg/ml penicillin and
Materials and methods
100 μg/ml streptomycin. Aliquots of 10 6 cells were treated with adriamycin (1 μg/ml) or with clinical grade cisplatin (10 μg/ml) as Oligonucleotides indicated in the text. For immunoblotting cells were harvested, washed The following biotinylated oligonucleotides were employed: p53 conin PBS and lysed for 15 min on ice in lysis buffer (50 mM Tris-HCl, sensus (CON, 20 bp), 5Ј-GGACATGCCCGGGCATGTCC-3Ј (Funk pH 7.5, 250 mM NaCl, 0.1% Triton and 5 mM DTT) containing et al., 1992); L-DNA, 5Ј-GGCTCGAACCCGTTCTCGGAGCACCCCTphenylmethylsulfonyl fluoride (1 mM), leupeptin (2 μg/ml) and aprotinin GCCCCAGCCCAACCGCTTTGGCCGCCGCCCAGCC-3Ј (62b), triple (2 μg/ml) as protease inhibitors. Protein concentrations were determined cytosine lesions are underlined (Lee et al., 1995) . The oligonucleotides by the Bradford reaction and equivalent aliquots were subject to SDSwere annealed as follows: pCON to itself, L-DNA oligonucleotide to PAGE and immunoblotting as detailed in the text. For cell cycle analysis the biotinylated reverse sequence 5Ј-GGCTGGGCGGCGGCCAAAGCthe cells were washed in PBS and fixed in ice-cold methanol (70% in GGTTCTGCAGTGCTCCGAGAACGGGTTCGAGCC-3Ј (53b). The PBS) for 20 min at -20°C. The cells were then resuspended in 1 μg/ml latter was used as an ssDNA template for the experiments when p53
RNase in PBS and incubated at 37°C for 30 min. Propidium iodide was exposed to ssDNA. According to the experiment it was biotinylated (50 μg/ml) was then added and cell cycles were analysed using on the 5Ј-or 3Ј-end.
a FACSort (Becton-Dickinson). Apoptotic cells were assessed by a combination of DNA content and by labelling with annexin V.
Baculoviral expression and purification of p53
Human and murine p53-producing recombinant baculoviruses were
